Search
Search
Search
Close this search box.

Investors Press Releases

Xybion Digital Inc. Press Releases

Xybion Launches Digital Pathology for Research and Development

PRINCETON, N.J., August 23, 2021 – Xybion Corporation, a global low-code SaaS company that enables digital transformation in highly regulated industries including Life Sciences announced the release of Pristima XD Digital Pathology. Xybion’s Digital Pathology software provides improved lab throughput while allowing pathologists to streamline their peer-review workflows. The Digital Pathology module from Xybion offers the first preclinical laboratory information system of its kind that is fully integrated into the digital pathology workflow and provides efficient pathological studies of whole slides.

This novel digital pathology software provides remote peer review across pathology labs providing compliant preclinical non-GLP animal studies in research and development labs. Implementation of Xybion’s scanner agnostic Digital Pathology software provides flexibility for laboratories with multiple scanners or different scanners across multiple sites.

In addition to being slide scanner agnostic, this innovative Digital Pathology software improves the overall productivity of non-GLP studies by reducing turnaround times, increasing efficiencies, reducing storage and retrieval times of glass slides, and simplifies the sharing of annotated slides.

Key Benefits of Digital Pathology

  • Only preclinical Laboratory Information Management Systems (LIMS) with an integrated digital pathology workflow
  • Provides a regulatory framework for tissue collection, slide creation, and sample tracking as part of a complete preclinical study process.
  • Integrated with an image management system, Xybion’s Digital Pathology platform enhances slide review with real-time image sharing between pathologists and researchers across multiple sites worldwide.
  • Digital metadata can be utilized to populate Standard for Exchange of Nonclinical Data (SEND) as a component of your FDA submissions
  • Xybion Digital Pathology software is both scanner and image format agnostic allowing pathology labs to use their current system and reduce costs
  • Only system capable of reading DICOM format images from multiple image types.
 

Xybion’s Digital Pathology software enables users to load their scanned pathology slides into the system for viewing and reading. As part of a complete preclinical toxicology study process, Pristima XD facilitates necropsy tissue collection and slide creation and tracking. The glass slides can then be scanned using any scanning system. Once loaded into the Pristima XD Digital Pathology component, the digital slide images will be viewable and annotated by pathologists while they are entering their study findings in Pristima’s Pathology module.

“We are seeing rapid adoption of digital pathology across the industry. Pathologists who intend to modernize their laboratory systems with the latest digital pathology system identify with the trend that digital pathology is the next wave of high-tech components creating effective lab operations with the potential to improve diagnosis and slide analysis through artificial intelligence and machine learning. Xybion’s leading-edge solution significantly improves end-to-end pathology processes for today’s all-digital, all-remote world.,” said Pradip K. Banerjee, Ph.D., Chairman & CEO of Xybion.

To learn more about Xybion Intelligent Digital Pathology, visit: https://www.xybion.com/pristima-xd/digital-pathology-software/

About Xybion Corporation

Xybion is a leading SaaS company dedicated to providing life sciences and health systems companies with innovative software solutions to accelerate the transformation of today’s inventions into tomorrow’s approved medicines, devices, and diagnostic tests designed to save lives and keep employees safe. Our intelligent cloud platform and software solutions help companies accelerate digital transformation of processes, speed up innovation, optimize operations, reduce compliance risks, and achieve significant cost savings. Xybion is serving over 160 customers in 25 countries including all the top 20 global biopharmaceutical companies.

Xybion’s global scale and expertise brings employees around the world to help companies in life sciences, health systems, research institutions, and governments. We put over 40 years of expertise in action every day to help companies digitally transform their regulated business operations. Our unique solutions focus on employee health and safety, integrated preclinical lab management, early-stage drug discovery, digital lab solutions, regulatory compliance, GRC, quality management, predictive compliance, content management, and systems validation.

Learn more about Xybion at https://www.xybion.com/

Contacts

Media
Joseph Kalina
Xybion Corporation
609-512-5790 x 316
[email protected]

Share Press Release

LinkedIn
Facebook
Twitter
Pinterest
Reddit
WhatsApp
Email

Contact Investor Relations

Investor relations serves prospective investors like you seeking insight about Xybion Digital's operations, strategies, vision, and investment options.

Connect with our investor relations team today.